Company / EPS (Diluted)
LIXTE BIOTECHNOLOGY HOLDINGS, INC. EPS (Diluted) History
FY2011-FY2015 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest EPS (Diluted)
-$0.06
FY2015
5-year range
-$0.09 / -$0.03
FY2011-FY2015
Trend
+33.3%
vs FY2014
Sector context
Sector data unavailable
Latest sector comparison
What the data says
EPS (Diluted) returned to growth in FY2015 after 2 years of decline, reaching $-0.06.
Based on SEC 10-K filings.
-0.06 in FY2015.
Remained stable around $-0.06 over the past 3 years.
EPS (Diluted) over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2015, eps (diluted) increased 33.3% year-over-year.
Company context
Key Data Points
- Altman Z-Score -11.44 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | EPS (Diluted)Value | YoY GrowthYoY |
|---|---|---|
| FY2015 | -$0.06 | +33.3% |
| FY2013 | -$0.09 | -50.0% |
| FY2012 | -$0.06 | -100.0% |
| FY2011 | -$0.03 | - |
As of FY2015 · SEC 10-K · Updated Jun 24, 2026